Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 60.24%10.61M | 48.65%10.59M | -13.75%5.71M | -22.15%27.15M | -35.40%6.78M | -20.01%6.62M | -18.00%7.12M | -10.64%6.62M | 17.14%34.87M | 45.58%10.5M |
| Operating revenue | 60.24%10.61M | 48.65%10.59M | -13.75%5.71M | -22.15%27.15M | -35.40%6.78M | -20.01%6.62M | -18.00%7.12M | -10.64%6.62M | 17.14%34.87M | 45.58%10.5M |
| Cost of revenue | 63.41%7.13M | 56.18%7.21M | -11.71%3.88M | -25.89%17.59M | -45.34%4.21M | -17.09%4.37M | -19.34%4.62M | -12.84%4.4M | 10.79%23.74M | 48.35%7.7M |
| Gross profit | 54.09%3.47M | 34.77%3.38M | -17.78%1.83M | -14.18%9.56M | -8.09%2.57M | -25.13%2.25M | -15.40%2.5M | -5.95%2.23M | 33.44%11.14M | 38.47%2.8M |
| Operating expense | -1.94%6.32M | 21.93%5.41M | 12.10%5.41M | 1.21%20.44M | -16.46%4.73M | 36.76%6.45M | -10.66%4.44M | -4.09%4.82M | 29.99%20.2M | 2.62%5.67M |
| Selling and administrative expenses | 58.98%3.57M | 37.81%2.81M | 4.76%2.74M | -5.51%9.04M | 21.05%2.14M | -8.94%2.24M | -21.44%2.04M | -4.45%2.62M | 4.76%9.56M | -28.59%1.77M |
| -Selling and marketing expense | -3.08%321.56K | 7.74%428.13K | -53.78%135.58K | -39.48%1.12M | -63.81%100.88K | -38.75%331.76K | -36.90%397.36K | -27.77%293.34K | -16.58%1.86M | -51.56%278.78K |
| -General and administrative expense | 69.75%3.25M | 45.08%2.38M | 12.16%2.61M | 2.67%7.91M | 36.96%2.04M | -0.54%1.91M | -16.49%1.64M | -0.39%2.32M | 11.64%7.71M | -21.63%1.49M |
| Research and development costs | -79.21%834 | --4.39K | -0.71%11.76K | -96.92%41.28K | -96.71%25.43K | -96.17%4.01K | --0 | -88.21%11.84K | 147.93%1.34M | 42.67%771.86K |
| Depreciation amortization depletion | 3.08%1.33M | 28.04%1.43M | 36.28%1.5M | 19.61%4.82M | -20.14%1.32M | 53.41%1.29M | 40.03%1.12M | 47.37%1.1M | 116.08%4.03M | 51.55%1.65M |
| -Depreciation and amortization | 3.08%1.33M | 28.04%1.43M | 36.28%1.5M | 19.61%4.82M | -20.14%1.32M | 53.41%1.29M | 40.03%1.12M | 47.37%1.1M | 116.08%4.03M | 51.55%1.65M |
| Other taxes | ---- | ---210.38K | --210.38K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other operating expenses | -51.16%1.42M | 7.45%1.38M | -13.61%948.29K | 24.34%6.54M | -15.25%1.26M | 123.29%2.9M | 5.91%1.28M | -24.08%1.1M | 31.44%5.26M | 4.26%1.48M |
| Operating profit | 32.04%-2.85M | -5.32%-2.04M | -37.70%-3.58M | -20.11%-10.89M | 24.64%-2.16M | -146.02%-4.19M | 3.69%-1.94M | 2.44%-2.6M | -25.98%-9.06M | 18.09%-2.87M |
| Net non-operating interest income (expenses) | -88.82%-1.87M | -285.98%-1.9M | -70.32%-645.69K | -65.38%-2.94M | -60.54%-1.07M | -133.23%-992.81K | -33.37%-491.66K | -21.13%-379.11K | -237.35%-1.78M | -167.40%-667.95K |
| Non-operating interest expense | 88.82%1.87M | 285.98%1.9M | 70.32%645.69K | 71.49%2.85M | 77.81%991.23K | 133.23%992.81K | 33.37%491.66K | 32.85%379.11K | 247.54%1.66M | 175.20%557.45K |
| Total other finance cost | ---- | ---- | ---- | -26.60%81.11K | ---- | ---- | ---- | -35.50%17.81K | 133.95%110.5K | ---- |
| Other net income (expenses) | 160.15%184.28K | -111.98%-41.31K | -354.56%-61.21K | -66.31%229.65K | -73.01%204.78K | -246.28%-306.37K | 532.11%344.71K | 49.68%-13.47K | -70.90%681.64K | -63.08%758.79K |
| Gain on sale of security | 229.20%140.88K | -329.00%-58.41K | -1,585.41%-57.74K | 136.76%12.9K | -64.51%92.54K | -648.06%-109.04K | 121.08%25.51K | 126.46%3.89K | 77.72%-35.09K | 253.43%260.77K |
| Special income (charges) | 100.31%597 | --0 | --0 | -48.20%363.32K | -49.05%246.12K | -185.09%-194.66K | --319.04K | 31.65%-7.18K | -66.42%701.32K | -76.76%483.06K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | 59.30%-247.66K | ---- | ---- | ---- | ---- | 70.72%-608.54K | ---- |
| -Gain on sale of property,plant,equipment | 100.31%597 | --0 | --0 | 24.65%115.66K | 98.77%-1.54K | -185.09%-194.66K | --319.04K | 31.65%-7.18K | 830.71%92.78K | -30,408.21%-125.48K |
| Other non-operating income (expenses) | 1,703.71%42.8K | 11,079.08%17.1K | 65.89%-3.47K | -1,051.43%-146.57K | -995.25%-133.88K | 93.20%-2.67K | -99.63%153 | -552.63%-10.17K | -96.26%15.41K | -89.78%14.96K |
| Income before tax | 17.34%-4.54M | -91.00%-3.98M | -43.26%-4.29M | -33.83%-13.59M | -9.08%-3.03M | -185.97%-5.49M | 15.28%-2.08M | 0.40%-2.99M | -88.86%-10.16M | -63.82%-2.78M |
| Income tax | 38.94%-283.46K | -750.97%-464.22K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 17.34%-4.54M | -91.00%-3.98M | -43.26%-4.29M | -37.31%-13.31M | -18.73%-2.74M | -185.97%-5.49M | 15.28%-2.08M | 0.40%-2.99M | -77.87%-9.69M | -30.91%-2.31M |
| Net income continuous operations | 17.34%-4.54M | -91.00%-3.98M | -43.26%-4.29M | -37.31%-13.31M | -18.73%-2.74M | -185.97%-5.49M | 15.28%-2.08M | 0.40%-2.99M | -77.87%-9.69M | -30.91%-2.31M |
| Noncontrolling interests | 111.66%5.95K | -5,602.66%-710.84K | 42.66%-43.68K | 26.51%-168.72K | 90.75%-29.08K | -110.05%-50.99K | 59.45%-12.47K | 80.54%-76.18K | 72.22%-229.58K | -314.56K |
| Net income attributable to the company | 16.45%-4.55M | -57.81%-3.27M | -45.50%-4.24M | -38.86%-13.14M | -35.97%-2.72M | -124.12%-5.44M | 14.72%-2.07M | -11.61%-2.92M | -104.70%-9.46M | -112.62%-2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 16.45%-4.55M | -57.81%-3.27M | -45.50%-4.24M | -38.86%-13.14M | -35.97%-2.72M | -124.12%-5.44M | 14.72%-2.07M | -11.61%-2.92M | -104.70%-9.46M | -112.62%-2M |
| Diluted earnings per share | 50.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.04 | -0.0058 | -100.00%-0.02 | 10.75%-0.01 | 10.75%-0.01 | -78.50%-0.04 | 0 |
| Basic earnings per share | 50.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.04 | -0.0058 | -100.00%-0.02 | 10.75%-0.01 | 10.75%-0.01 | -78.50%-0.04 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.